Previous findings from the reported literature as well as findings from our study direct towards potentially substantial evidence of related elevated expression of HIF-1α, MDR1 and LAPTM4B as an indicator of tumor progression, higher tumor stage and resistance to chemotherapy in breast, ovarian, colon and prostate cancer. This evidence concerns the gene LAPTM4B and Familial prostate cancer.